Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Prospective randomized controlled blinded clinical trial evaluating biomarkers of acute kidney injury following 6% hydroxyethyl starch 130/0.4 or Hartmann's solution in dogs

Boyd, C.J.ORCID: 0000-0003-1361-2148, Sharp, C.R.ORCID: 0000-0002-1797-9783, Claus, M.A.ORCID: 0000-0003-1529-1480, Raisis, A.L., Hosgood, G. and Smart, L.ORCID: 0000-0003-4776-2849 (2021) Prospective randomized controlled blinded clinical trial evaluating biomarkers of acute kidney injury following 6% hydroxyethyl starch 130/0.4 or Hartmann's solution in dogs. Journal of Veterinary Emergency and Critical Care . Early View.

Link to Published Version: https://doi.org/10.1111/vec.13056
*Subscription may be required

Abstract

Objective: To evaluate the effect of 6% hydroxyethyl starch (HES) 130/0.4, compared with a Hartmann's solution control (CRYST), on urine biomarkers of acute kidney injury (AKI) in dogs prescribed a fluid bolus.

Design: Randomized, controlled, blinded clinical trial January 2018 to February 2019.

Setting: University teaching hospital.

Animals: Forty client‐owned dogs.

Interventions: Dogs prescribed a fluid bolus were randomized to receive at least 10 mL/kg of HES or CRYST with clinicians and investigators blinded to fluid type. Study fluid was used for further boluses as required in the following 24 hours, to a limit of 40 mL/kg total, after which fluid administration was open‐label.

Measurements and Main Results: Urine was collected prior to and 6, 12, and 24 hours after the first study fluid bolus. Urine concentrations of AKI biomarkers: neutrophil gelatinase‐associated lipocalin (NGAL), cystatin C, kidney injury molecule‐1 (KIM), clusterin, and osteopontin were measured using a magnetic bead multiplexed assay. Osmolality‐indexed biomarker concentrations were compared between groups over time with linear mixed‐effects models, with P < 0.05 considered significant. The mean volume of study fluid administered was not significantly different between groups (HES: 23.1 mL/kg, CRYST: 25.9 mL/kg; P = 0.47, t‐test). There were no significant differences between groups in change over time of osmolality‐indexed urine concentrations of NGAL (P = 0.91), cystatin C (P = 0.95), KIM (P = 0.77), clusterin (P = 0.63), or osteopontin (P = 0.91). The maximum Veterinary Acute Kidney Injury (VAKI) score up to 7 days during hospitalization (P = 1.0) and in‐hospital mortality (P = 0.49) were not significantly different between groups, as compared by Fisher's exact test.

Conclusions: There were no differences in change over time of urine AKI biomarkers in dogs treated with 10 – 40 mL/kg HES or CRYST over 24 hours. Larger clinical trials with patient‐centered outcomes are required to investigate the safety of HES in dogs.

Item Type: Journal Article
Murdoch Affiliation(s): Veterinary Medicine
Publisher: Blackwell Publishing Inc.
Copyright: © 2021 Veterinary Emergency and Critical Care Society
URI: http://researchrepository.murdoch.edu.au/id/eprint/60113
Item Control Page Item Control Page